Document is current

Any future updates will be listed below

A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients

Crossref DOI link: https://doi.org/10.1186/S40064-015-1603-5

Published Online: 2015-12-22

Published Print: 2015-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark